Press release
United States Treatment-Resistant Depression Market Trends and Forecast 2024-2031: Antipsychotics, SSRIs, SNRIs, and Novel Treatment Developments
Treatment-Resistant Depression Market
According to DataM Intelligence has published a new research report on "Treatment-Resistant Depression Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
📌 Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/treatment-resistant-depression-market?rk
➣ Recent Developments:
United States: Recent Developments - Treatment-Resistant Depression (TRD)
✅ August 2025 - The FDA approved a new esketamine nasal spray formulation with extended dosing intervals, improving patient adherence and outpatient management for TRD.
✅ July 2025 - Biotech companies launched AI-driven personalized therapy platforms integrating pharmacogenomic data to optimize antidepressant selection for TRD patients.
✅ June 2025 - Clinical trials for novel psychedelic-based therapies (psilocybin and MDMA derivatives) demonstrated rapid symptom reduction in patients unresponsive to conventional treatments.
Europe: Recent Developments - Treatment-Resistant Depression (TRD)
✅ August 2025 - Germany: European regulators approved deep brain stimulation (DBS) devices for severe TRD, providing targeted neuromodulation therapy.
✅ July 2025 - UK: NHS pilot programs integrated AI-based remote monitoring tools to track treatment response and optimize therapy adjustments for TRD patients.
✅ June 2025 - France: New clinical trials explored multi-modal combination therapies, pairing novel antidepressants with psychotherapy and neuromodulation to enhance efficacy.
➣ Top Industry Players:
Pfizer Inc., Viatris Inc., Novartis AG, AbbVie Inc., Eli Lilly and Company, Otsuka America Pharmaceutical, Inc., AstraZeneca, Camber Pharmaceuticals, Inc., Biodesix and Validus Pharmaceuticals LLC
📌 Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @: https://www.datamintelligence.com/buy-now-page?report=treatment-resistant-depression-market?rk
➣ Key Segments:
By Drugs: Antipsychotics (Aripiprazole (Abilify), Brexpiprazole (Rexulti), Quetiapine (Seroquel), Olanzapine (Zyprexa), Selective Serotonin Reuptake Inhibitors (SSRIs) (Fluoxetine (Prozac), Sertraline (Zoloft), Citalopram (Celexa), Paroxetine (Paxil), Serotonin and Noradrenaline Reuptake Inhibitors (SNRIs) (Duloxetine (Cymbalta), Venlafaxine (Effexor XR), Desvenlafaxine (Pristiq), Monoamine Oxidase Inhibitors (MAOIs) (Phenelzine (Nardil), Isocarboxazid (Marplan), Others
By Route of Administration: Oral, Injectable, Others
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
📌 Get Customization in the report as per your requirements: https://datamintelligence.com/customize/treatment-resistant-depression-market?rk
📌 Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/treatment-resistant-depression-market?rk
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
☛ Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?rk
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Treatment-Resistant Depression Market Trends and Forecast 2024-2031: Antipsychotics, SSRIs, SNRIs, and Novel Treatment Developments here
News-ID: 4300836 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Mannan Oligosaccharide Market to Reach USD 1.45 Billion by 2031 - Asia-Pacific D …
Leander, Texas and Paris, France - Dec 04, 2025
According to DataM Intelligence, the global mannan oligosaccharide market size was valued at US$0.85 billion in 2023 and is forecasted to reach US$1.45 billion by 2031, growing at a CAGR of 6.9% from 2024 to 2031. This steady growth is propelled by increasing demand for prebiotics to enhance gut health and immunity, rising livestock production for animal-based nutritious products, expanding applications in…
Automatic Packaging Robot Market Trends and Forecast 2024-2031: Focus on AI Visi …
Global Automatic Packaging Robot Market reached US$ 4.0 billion in 2023 and is expected to reach US$ 10.2 billion by 2031, growing with a CAGR of 12.4% during the forecast period 2024-2031.
According to DataM Intelligence has published a new research report on "Automatic Packaging Robot Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key…
Beer Processing Market to Hit USD 3.75 Billion by 2031 - Craft Breweries (40% Sh …
Leander, Texas and Paris, France - Dec 04, 2025
According to DataM Intelligence, the global beer processing market size was valued at US$2.50 billion in 2023 and is forecasted to reach US$3.75 billion by 2031, growing at a CAGR of 4.2% from 2024 to 2031. This moderate growth is propelled by rising number of microbreweries and brewpubs, increasing consumer preference for premium and flavored craft beers, expanding demand for low/no-alcohol and…
United States Transient Protein Expression Market Advances at 5.9% CAGR - $600 M …
Leander, Texas and TOKYO, Japan - Dec. 04, 2025. According to DataM Intelligence, the United States Transient Protein Expression Market Size is growing from USD 320 million in 2023 to USD 600 million by 2031, registering a robust CAGR of 5.9% during 2024-2031. The surging demand for accelerated drug discovery platforms, the expansion of gene and cell therapy pipelines, and advancements in transfection optimization technologies are fueling the need for…
More Releases for Depression
Ace Therapeutics Accelerates Preclinical Depression Investigation by Providing D …
Ace Therapeutics released depression-related behavior tests to accelerate preclinical depression research.
New York, USA - December 24, 2024 - Ace Therapeutics, a preclinical contract research provider dedicated to offering comprehensive one-stop services, released the expansion of its research capabilities in the area of depression through the introduction of comprehensive depression-related behavior tests [https://www.acetherapeutics.com/psychiatry/depression-behavior-tests.html] in its preclinical investigation processes. This integral development aims to enhance the understanding of depressive disorders and expedite…
Postpartum Depression Global Market Report 2024 - Postpartum Depression Market S …
The Business Research Company recently released a comprehensive report on the Global Postpartum Depression Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The postpartum depression market…
Depression Apps Market - Tools for Resilience, Tools for Life: Depression Apps f …
Newark, New Castle, USA: The "Depression Apps Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Depression Apps Market: https://www.growthplusreports.com/report/depression-apps-market/8782
This latest report researches the industry structure, sales, revenue,…
Depression Apps Market - Navigating the Path to Mental Wellbeing: Harnessing the …
Newark, New Castle, USA - new report, titled Depression Apps Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Depression Apps market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Depression Apps market. The report offers an overview of the market, which…
Depression Treatment Device Market: Information by Product Type (Light Therapies …
Depression is characterized by multiple mental health challenges that involve a lack of positivity, suicidal thoughts, insomnia, anxiety, loss of appetite, and sadness. Depression is caused by a combination of biological, genetic, environmental, and psychological factors. Globally, the prevalence of depression is increasing at an alarming rate. About 300 million people of all ages suffered from depression and the suicide rate rose to about 8,00,000 individuals in 2018. As per…
Depression Drugs Market: Increase in Cases of Depression to Boost Market Growth
Transparency Market Research (TMR) has published a new report titled, “Depression Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global depression drugs market was valued at US$ 6,500 Mn in 2017 and is anticipated to decline at a CAGR of 2% from 2018 to 2026. The report suggests that rise in incidence of major depression disorders is projected to drive…
